Found: 6
Select item for more details and to access through your institution.
Fusion of HCV Nonstructural Antigen to MHC Class II-associated Invariant Chain Enhances T-cell Responses Induced by Vectored Vaccines in Nonhuman Primates.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 5, p. 1039, doi. 10.1038/mt.2014.15
- By:
- Publication type:
- Article
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 627, p. 1, doi. 10.1126/scitranslmed.abj1996
- By:
- Publication type:
- Article
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3009185
- By:
- Publication type:
- Article
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 115, p. 1, doi. 10.1126/scitranslmed.3002925
- By:
- Publication type:
- Article
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 115, p. 1, doi. 10.1126/scitranslmed.3003155
- By:
- Publication type:
- Article
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.
- Published in:
- Nature Medicine, 2014, v. 20, n. 10, p. 1126, doi. 10.1038/nm.3702
- By:
- Publication type:
- Article